These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 35811188

  • 21. Sodium zirconium cyclosilicate: a new potassium binder for the treatment of hyperkalemia.
    Cases A, Gorriz JL.
    Drugs Today (Barc); 2018 Oct; 54(10):601-613. PubMed ID: 30398481
    [Abstract] [Full Text] [Related]

  • 22. The effect of sodium zirconium cyclosilicate on acid-base balance in chronic kidney disease.
    Mori D, Namiki Y, Sugimachi A, Kado M, Tamai S, Nomi H, Haga R, Nagatoya K, Yamauchi A.
    Clin Nephrol; 2022 May; 97(5):255-260. PubMed ID: 34958299
    [Abstract] [Full Text] [Related]

  • 23. Evaluation of the tolerability and efficacy of sodium polystyrene sulfonate for long-term management of hyperkalemia in patients with chronic kidney disease.
    Georgianos PI, Liampas I, Kyriakou A, Vaios V, Raptis V, Savvidis N, Sioulis A, Liakopoulos V, Balaskas EV, Zebekakis PE.
    Int Urol Nephrol; 2017 Dec; 49(12):2217-2221. PubMed ID: 29027620
    [Abstract] [Full Text] [Related]

  • 24. Potassium homeostasis and therapeutic intervention with sodium zirconium cyclosilicate: A model-informed drug development case study.
    Clegg LE, Chu L, Nagard M, Boulton DW, Penland RC.
    CPT Pharmacometrics Syst Pharmacol; 2024 Feb; 13(2):296-307. PubMed ID: 38050337
    [Abstract] [Full Text] [Related]

  • 25. Fecal ammonium in mice with CKD: gastrointestinal sequestration by sodium zirconium cyclosilicate.
    Marmol F, Badaruddin M, Baig A, Ye M, Wysocki J, Tahaei E, Welling P, Bamberg K, Batlle D.
    Am J Physiol Renal Physiol; 2023 May 01; 324(5):F464-F471. PubMed ID: 37022945
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Sodium Zirconium Cyclosilicate: A Review in Hyperkalaemia.
    Hoy SM.
    Drugs; 2018 Oct 01; 78(15):1605-1613. PubMed ID: 30306338
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Pharmacodynamics and pharmacokinetics of sodium zirconium cyclosilicate [ZS-9] in the treatment of hyperkalemia.
    Packham DK, Kosiborod M.
    Expert Opin Drug Metab Toxicol; 2016 May 01; 12(5):567-73. PubMed ID: 26998854
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.